Men

A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer

Providence Cancer Institute presents a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.

Sexual function isn’t easy to talk about, but Providence’s Dan Getz, D.O., explains why men need to find a provider they’re comfortable discussing it with.

Providence Chief Medical Officer Dan Getz, D.O., explains how getting a good night’s sleep can improve men’s mental health and overall wellness.

Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.

Providence Chief Medical Officer Dan Getz, D.O., says exercise and nutrition is key to men’s health and wellness, including strong heart and brain health.

Providence Chief Medical Officer Dan Getz, D.O., focuses on prevention for men’s health, as well as early detection of cancer and other illness.

In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.

In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.

Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.

The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).

New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.

Providence hematology oncologist and outdoors enthusiast Eric C. Anderson, M.D., shares his love of the Pacific Northwest and his philosophy of care for patients.

A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.

The theme for International Men’s Day 2023 is “Zero Male Suicide,” so Providence is focusing on some of the ways we can reduce the suicide rate.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Using MRI-guided radiation, Providence radiation oncologists can precisely target tumors for destruction while minimizing damage to surrounding normal tissue.